ADHERENCE AND ITS ASSOCIATION WITH HEALTH OUTCOMES AMONG PATIENTS CURRENTLY TREATED FOR LEUKEMIA, MELANOMA, OR NON-SMALL CELL LUNG CANCER (NSCLC)

被引：3
|
作者：
Goren, A. [1 ]
DiBonaventura, M. [1 ]
Wagner, R. [2 ]
机构：
[1] Kantar Hlth, New York, NY USA
[2] Kantar Hlth, Montrouge, France
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 03期
关键词：
D O I：
10.1016/j.jval.2013.03.709
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A144 / A145
页数：2
相关论文
共 50 条
  • [1] Fear of cancer recurrence and its predictors among patients with non-small cell lung cancer (NSCLC)
    Jung, Wonyoung
    Park, Junhee
    Jeong, Ansuk
    Cho, Jong Ho
    Jeon, Yeong Jeong
    Shin, Dong Wook
    JOURNAL OF CANCER SURVIVORSHIP, 2024, 18 (06) : 1782 - 1789
  • [2] Association of the EGFR gene polymorphisms with clinical outcomes in patients with advanced non-small cell lung cancer (NSCLC) treated with gefitinib
    Ma, F.
    Lin, D.
    Sun, T.
    Chu, D.
    Zhang, X.
    Wang, Z.
    Wang, J.
    Shi, Y.
    Sun, Y.
    Xu, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [3] Clinical Outcomes and Lack of Health Equity in Minority Patients with Unresectable Non-small Cell Lung Cancer (NSCLC) Treated with Durvalumab
    Fares, A.
    Theik, N.
    Dumais, K.
    Walker, D.
    Rodriguez, M.
    Dickson, F.
    Swaby, G.
    Alvarez, A. M.
    Raez, L. E.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S741 - S741
  • [4] Serum EGFR in patients with non-small cell lung cancer (NSCLC) treated with gefitinib
    Spreafico, A
    Gregorc, V
    Ludovini, V
    Pistola, L
    Amoroso, M
    Tofanetti, F
    Compagnoni, A
    Aondio, G
    Tonato, M
    Villa, E
    LUNG CANCER, 2005, 49 : S112 - S113
  • [5] Factors associated with adherence to chemotherapy guidelines in patients with non-small cell lung cancer (NSCLC)
    Salloum, R. G.
    Smith, T. J.
    Elston-Lafata, J.
    Jensen, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [6] Immunotherapy in previously treated non-small cell lung cancer (NSCLC)
    Leal, Ticiana A.
    Ramalingam, Suresh S.
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S422 - S432
  • [7] Outcomes of Nivolumab in Elderly Patients (pts) with Non-Small Cell Lung Cancer (NSCLC)
    Bagley, Stephen
    Kothari, Shawn
    Aggarwal, Charu
    Bauml, Joshua
    Alley, Evan
    Evans, Tracey
    Kosteva, John
    Ciunci, Christine
    Thompson, Jeffrey
    Stonehouse-Lee, Susan
    Sherry, Victoria
    Gilbert, Elizabeth
    Eaby-Sandy, Beth
    Mutale, Faith
    Dilullo, Gloria
    Cohen, Roger
    Vachani, Anil
    Langer, Corey
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1289 - S1289
  • [8] NRAS mutated non-small cell lung cancer (NSCLC) patients: Characteristics and outcomes
    Dehem, A.
    Mazieres, J.
    Chour, A.
    Guisier, F.
    Ferreira, M.
    Boussageon, M.
    Girard, N.
    Moro-Sibilot, D.
    Cadranel, J.
    Zalcman, G.
    Ricordel, C.
    Wislez, M.
    Munck, C.
    Poulet, C-H.
    Gauvain, C.
    Descarpentries, C.
    Wasielewski, E.
    Cortot, A. B.
    Baldacci, S.
    ANNALS OF ONCOLOGY, 2021, 32 : S1023 - S1024
  • [9] Non-small cell lung cancer (NSCLC) in elderly patients
    Batura-Gabryel, H.
    Brajer, B.
    LUNG CANCER, 2006, 52 : S19 - S19
  • [10] The association of toxicities and outcomes with circulating endothelial cells (CEC) in non-small cell lung cancer (NSCLC) patients (pts) treated with bevacizumab (Bev).
    Sadraei, Nooshin Hashemi
    Du, Lingling
    Yadav, Ruchi
    Grane, Ronald
    Jacobs, Barbara
    Hamulak, John
    Ma, Patrick C.
    Pennell, Nathan A.
    Elson, Paul
    Borden, Ernest C.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345